Working Through the HHMI Cell Cycle Module
The HHMI BioInteractive eukaryotic cell cycle and cancer module is a standalone web-based activity that most biology instructors assign in upper-level high school or introductory college courses. It asks students to analyze flow cytometry-style data, map cell population percentages onto cell cycle phases, and then connect that data to mechanisms of cancer. The answer key exists as a companion document rather than something officially published on HHMI's site, so you will find it scattered across teacher resource pages, shared Google Drive folders, and third-party study sites. The core activity breaks into three sections. First, students examine normal tissue data and assign cell percentages to G1, S, G2, and M phases based on microscopy or imaging data provided in the module. Second, they look at cancer tissue samples, often comparing tumor types like lung, breast, or liver cancer, and calculate the fraction of cells actively dividing. Third, they match observed data patterns to molecular mechanisms involving cyclins, CDKs, Rb, p53, and checkpoint pathways. The answer key walks through each of these steps with expected percentage ranges and the reasoning behind them. I ran through this module with a class last semester and hit a specific issue that the standard answer key does not address directly. The module includes a question asking students to interpret cell cycle data from a treatment that blocks microtubule function, similar to how certain chemotherapy drugs work. The answer key states that cells accumulate in M phase, which is correct in principle. However, the actual data table in the module shows a notable number of cells flagged as having abnormal morphologies rather than a clean, sharp peak in M. A student who followed the key literally would mark M phase as the only accumulation point, but the more accurate reading requires acknowledging that the treatment causes mitotic arrest with some cells progressing into a death pathway. I resolved this by having students note both the primary accumulation phase and the secondary observation of cell death artifacts in the data. That nuance is rarely spelled out in the standard key, but it matches what you see if you actually look at the raw images instead of just matching numbers.
The module itself does not require any special software. You open it in a browser, work through the interaction panels, and submit responses directly on the page. If you are looking for a downloadable answer key, the most reliable route is through the HHMI BioInteractive educator portal, where instructors can access the accompanying teaching materials after creating a free account. The document is typically labeled as part of the "Cell Cycle and Cancer" educator resources and includes both student answers and suggested discussion points. Some universities also host mirrored PDFs on their course management systems, but those copies sometimes lag behind updates to the interactive module itself. I have seen versions that still reference older cyclin nomenclature while the current module uses the updated CDK pairing labels, so always check the date on any file you pull from a third-party source. When grading or self-checking against the key, there are two common traps that catch people who are not careful. The first involves the calculation of the mitotic index. The module gives total cell counts per field and asks for the percentage of cells in M phase. Students sometimes divide the M count by the M count alone, which gives 100 percent and is obviously wrong. The correct denominator is the total cell count across all phases. The second trap appears in the cancer comparison section. The key provides expected ranges because the data is sampling-based, not absolute. If a student calculates a value that falls slightly outside the listed range but follows correct arithmetic, the key will mark it as incorrect unless the grader understands the margin of sampling error. I usually tell people to accept values within roughly ten percent of the key's midpoint when the sample size is small, since the underlying data comes from limited field counts rather than a full population census. The module's strength is that it forces students to work from real data instead of memorizing phase definitions. The weakness is that the interface does not always make clear which data points are primary observations and which are interpretations the student is supposed to infer. There is also a bottleneck in the cancer mechanism section where the activity assumes familiarity with the Rb-E2F pathway and p53 checkpoint logic. Students who have not recently reviewed those pathways tend to stall because the module presents the molecular connections as part of the analysis rather than teaching them from scratch. If you are working through this alone, I would keep a basic molecular biology reference open alongside the activity. Something like a current textbook chapter on cell cycle regulation or the HHMI itself's separate short film on cancer and the cell cycle will fill gaps faster than re-reading the module panels repeatedly.
One detail worth noting is that the answer key occasionally lists cyclin B as the primary marker for M phase entry while the module questions sometimes refer to cyclin A in the S-to-G2 transition. Both are correct in their respective contexts, but the key does not always spell out why one cyclin appears in one answer and the other in another. The practical workaround is to link cyclin A to S phase progression and DNA replication checkpoint control, and cyclin B to G2/M transition and mitotic entry. That distinction aligns with the data the module presents and prevents confusion when the answer key shifts between the two. If the HHMI module does not fit your needs, there are alternatives with similar data analysis focus. The Cold Spring Harbor Laboratory has a comparable cell cycle data analysis exercise, and some university genetics departments publish flow cytometry interpretation worksheets that use the same basic approach. Those alternatives are useful when you need more advanced statistical treatment or different cancer types. The HHMI version remains one of the more accessible options because it is browser-based and free, but it is not the only path to the same learning outcome.
Get the Full Details
